OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ABOS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Acumen Pharmaceuticals (ABOS) Earnings Date & Reports

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABOS is expected to report earnings to fall 19.31% to -54 cents per share on November 17

Acumen Pharmaceuticals ABOS Stock Earnings Reports

Q3'25

Est.

$-0.55

Q2'25

Missed

by $0.17

Q1'25

Beat

by $0.03

Q4'24

Missed

by $0.13

Q3'24

Missed

by $0.14

The last earnings report on August 12 showed earnings per share of -68 cents, missing the estimate of -50 cents. With 184.10K shares outstanding, the current market capitalization sits at 86.01M.

View a ticker or compare two or three

Compare

ABOS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ABOS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABOS showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

427 Park Street

Phone

+1 434 297-1000

Employees

Web

https://www.acumenpharm.com